← Open Payments lookup

MICHELLE MARTIN: Open Payments

NPI 1053731406 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,941 in 161 payments from 29 companies in 2025. Trend: 2023 $2,016 · 2024 $3,747 · 2025 $3,941

Food & beverage: $3,941
CompanyPaymentsAmount
UCB, Inc.14$471
ABBVIE INC.21$413
Eisai Inc.11$339
PFIZER INC.14$317
Biogen, Inc.13$256
EMD Serono, Inc.8$224
Alexion Pharmaceuticals, Inc.8$217
SK Life Science, Inc.10$207
Genentech USA, Inc.9$183
Takeda Pharmaceuticals U.S.A., Inc.6$174

Products named: Leqembi, NURTEC ODT, QULIPTA, ULTOMIRIS, Ocrevus Zunovo, HYQVIA, TYSABRI, Nayzilam.

Industry payments across TX — which companies pay providers there.